Skip to main content
Clinical Trials/CTRI/2019/06/019604
CTRI/2019/06/019604
Recruiting
未知

Risk prediction for Contrast Induced Nephropathy in patients with renal impairment

GE Healthcare Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: I219- Acute myocardial infarction, unspecified
Sponsor
GE Healthcare Limited
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • All consecutive patients aged 18 to 80 years, who undergo PCI in the study sites can be enrolled into the study, if their GFR is 15\- 60ml/min/1\.73m2, in whom Iodixanol is the contrastmedia of choice. The screening tests required for the study must be performed in all patients.

Exclusion Criteria

  • Evidence of acute renal failure before PCI, patients on regular dialysis, cardiogenic shock, patients who were exposed to contrast media within 14 days, patients exposed to nephrotoxic medication within 48hours of the procedure, patients requiring intra\-aortic balloon pump (IABP) support and patients who developed PCI related complications will be ex¬cluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials